SA’s medicines regulator has revived the debate on the control of codeine and is considering ruling that popular painkillers and cough suppressants are sold on prescription-only, unless the industry can come up with a viable alternative.

Restricting codeine to prescription-only would reduce sales and hit local pharmaceutical manufacturer Adcock Ingram particularly hard, as it is the dominant player.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now